MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directoryAI-native adherence and patient engagement platform that uses smartphone workflows, computer vision, and analytics to support medication-taking verification and trial monitoring.
Organizations that need auditable medication adherence data for clinical trials, complex regimens, remote monitoring, or patient engagement programs.
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating AiCure as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as medication adherence, trial monitoring, and patient engagement support; verify whether the local use affects clinical trial endpoints, regulated evidence generation, remote patient monitoring, or patient-care decisions. |
|---|---|
| Privacy | Review captured video, facial images, biometric matching, medication-event data, PHI, sponsor/provider access, retention, encrypted storage, country filings, consent, and child or vulnerable-population notices before use. |
| Evidence | Validate adherence detection, missed-dose alerts, participant burden, equity across devices and populations, site intervention timing, and how adherence data changes trial or care decisions. |
| Workflow | Best governed with study-team or care-team review queues, participant support scripts, escalation paths, consent language, data-monitoring plans, and audit trails for every adherence intervention. |
AiCure describes H.Code and Patient Connect as AI-powered adherence and patient-engagement platforms for clinical trials and patient care; company privacy and security materials describe PHI handling, encrypted storage, HIPAA/GDPR/21 CFR Part 11 posture, ISO 27001 and SOC 2 certifications, and facial image and health-data processing that require careful consent and governance review.
Not for: Coercive medication monitoring, unsupervised dose changes, emergency medication management, or deployments without consent, privacy, and clinical oversight.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.